Treatment with guselkumab raised the chances for resolution of enthesitis among patients with psoriatic arthritis, according to a pooled analysis of two large international trials. Enthesitis, defined as inflammation of tendon, ligament, or joint capsule insertion sites to bone, is reported in up to 54% of all patients with psoriatic arthritis (PsA). “As a potential ...
Guselkumab produces sustained enthesitis resolution in psoriatic arthritis
By Dave Levitan
15 Apr 2021